ABBOTT INDIA LIMITED
- Country
- 🇮🇳India
- Ownership
- Private
- Established
- 1888-01-01
- Employees
- 73K
- Market Cap
- $7.5B
- Website
- http://www.abbott.com
Efficacy and Safety Study of Creon IR in Subjects With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis
- Conditions
- Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis
- Interventions
- First Posted Date
- 2015-04-14
- Last Posted Date
- 2016-04-04
- Lead Sponsor
- Abbott
- Target Recruit Count
- 70
- Registration Number
- NCT02415959
- Locations
- 🇨🇿
Dětská nemocnice FN Brno, Centrum pro cystickou fibrozu, Brno, Czech Republic
🇨🇿Klinika nemocí plicních a TBC, Brno, Czech Republic
🇭🇺Magyar Imre Kórház, Ajka, Hungary
Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the Southern Hemisphere 2015 Season
- Conditions
- Influenza
- Interventions
- Biological: Trivalent influenza subunit vaccine Influvac
- First Posted Date
- 2015-03-06
- Last Posted Date
- 2016-12-22
- Lead Sponsor
- Abbott
- Target Recruit Count
- 120
- Registration Number
- NCT02381418
- Locations
- 🇦🇺
Research Facility ID ORG-001075, Maroubra, Australia
A Retrospective, Open-label, Uncontrolled Cohort Study to Assess the Effectiveness and Safety of Lactulose Retention Enema in the Treatment of Cirrhotic Patients With Grade 3 or 4 (West Haven Criteria) Hepatic Encephalopathy (HE) [The RETRO Study]
- Conditions
- Hepatic Encephalopathy
- First Posted Date
- 2015-03-04
- Last Posted Date
- 2020-02-10
- Lead Sponsor
- Abbott
- Target Recruit Count
- 50
- Registration Number
- NCT02377947
- Locations
- 🇮🇳
Medanta Hospital, Gurgaon, India
🇮🇳Sir Ganga Ram Hospital, New Delhi, India
🇮🇳Research facility ORG-000333, Gurgaon, India
Sensitivity of Antibiotics for Urinary Tract Infections Patients Attending Family Physicians
- Conditions
- Urinary Tract Infections (UTIs)
- First Posted Date
- 2014-12-02
- Last Posted Date
- 2015-03-06
- Lead Sponsor
- Abbott
- Target Recruit Count
- 350
- Registration Number
- NCT02305342
- Locations
- 🇵🇰
Research facility ID ORG-001126, Karachi, Pakistan
An Observational Study to Describe the Effectiveness of Angiotensin Converting Enzyme Inhibitor and Calcium Channel Blocker Combination in the Management of Hypertensive Patients With Elevated Heart Rate and Type 2 Diabetes
- Conditions
- Hypertension
- First Posted Date
- 2014-11-24
- Last Posted Date
- 2018-03-27
- Lead Sponsor
- Abbott
- Target Recruit Count
- 270
- Registration Number
- NCT02298556
- Locations
- 🇹🇷
Research facility ID ORG-001030, Ankara, Turkey
🇹🇷Research facility ID ORG-001111, Antalya, Turkey
🇹🇷Research facility ID ORG-001108, Adana, Turkey
Effectiveness of Duspatalin® in Patients With Post-cholecystectomy Gastrointestinal Spasm
- First Posted Date
- 2014-10-09
- Last Posted Date
- 2019-06-06
- Lead Sponsor
- Abbott
- Target Recruit Count
- 220
- Registration Number
- NCT02260154
- Locations
- 🇷🇺
Research Facility ID ORG-001038, Izhevsk, Russian Federation
🇷🇺State Budget Institution " Irkutsk State Medical Academy of postgraduate education", Irkutsk, Russian Federation
🇷🇺Research Facility ID ORG-001035, Chita, Russian Federation
Study Immunology and Safety of 60-day Treatment of SQ Grass SLIT (Sublingual Immunotherapy)-Tablet in Adult Subjects With Grass Pollen-induced Allergic Rhinoconjunctivitis
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Drug: placeboDrug: Phleum pratense grass pollen allergen extract
- First Posted Date
- 2014-09-19
- Last Posted Date
- 2016-01-11
- Lead Sponsor
- Abbott
- Target Recruit Count
- 107
- Registration Number
- NCT02245360
- Locations
- 🇷🇺
Research facility ID ORG-001014, Moscow, Russian Federation
🇷🇺Research facility ID ORG-001006, Moscow, Russian Federation
🇷🇺Research facility ID ORG-001016, Moscow, Russian Federation
To Study the Characteristics of Different Types of Vertigo in Patients Attending the Ear Nose & Throat (ENT) Clinics.
- Conditions
- Vertigo
- First Posted Date
- 2014-08-11
- Last Posted Date
- 2015-05-28
- Lead Sponsor
- Abbott
- Target Recruit Count
- 400
- Registration Number
- NCT02213120
- Locations
- 🇵🇰
Research facility ID ORG-001139, Hyderabad, Pakistan
🇵🇰Research facility ID ORG-001070, Karachi, Pakistan
🇵🇰Research facility ID ORG-001051, Karachi, Pakistan
Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption
- Conditions
- Intrahepatic Cholestasis Associated With Alcoholic Liver Disease
- Interventions
- First Posted Date
- 2014-07-25
- Last Posted Date
- 2015-06-16
- Lead Sponsor
- Abbott
- Target Recruit Count
- 75
- Registration Number
- NCT02200029
- Locations
- 🇷🇺
Research facility ORG-000961, Moscow, Russian Federation
🇷🇺Research facility ORG-000967, St. Petersburg, Russian Federation
🇷🇺Research facility ORG-000966, St. Petersburg, Russian Federation
A Double-blind, Randomized, Multicenter, Cross-over Study to Compare the Effect of Creon N and Creon® on Fat Digestion in Subjects ≥ 12 Years of Age With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis
- Conditions
- Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis
- Interventions
- First Posted Date
- 2014-05-13
- Last Posted Date
- 2016-01-22
- Lead Sponsor
- Abbott
- Target Recruit Count
- 41
- Registration Number
- NCT02137382
- Locations
- 🇭🇺
Research facility ID ORG-000825, Törökbálint, Hungary
🇭🇺Research facility ID ORG-000816, Debrecen, Hungary
🇭🇺Research facility ID ORG-000826, Budapest, Hungary